Literature DB >> 8237919

A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome.

C Hull1, R J Hagerman.   

Abstract

The physical features of fragile X, including a long face, prominent ears, and hyperextensible joints, are present in affected males and females. Cytogenetically negative heterozygotes have been considered to be unaffected by the fragile X mental retardation-1 (FMR-1) gene. This study investigated the penetrance of the FMR-1 gene in cytogenetically negative but DNA-positive heterozygotes with a premutation (cytosine guanine guanine [CGG] amplification in the 50 to 200 repeat range), compared with carriers with a full mutation (> 200 CGG repeats) and control subjects. One hundred thirty-nine women with normal IQs between the ages of 18 and 45 years were studied. All underwent cytogenetic and DNA testing to determine their fragile X carrier status. A medical history-taking and a physical examination, including selected anthropometric measurements, were performed. Results indicate that the FMR-1 mutation mildly affects the physical phenotype of individuals even in the premutation state, although less dramatically than more affected heterozygotes. Carriers with a premutation differed significantly from control subjects in overall physical index score and in the anthropometric measure of ear prominence. These results suggest a phenotypic impact of the FMR-1 mutation even at the 50 to 200 CGG repeat length.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237919     DOI: 10.1001/archpedi.1993.02160350110017

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  13 in total

1.  Epigenetic regulation of neuronal dendrite and dendritic spine development.

Authors:  Richard D Smrt; Xinyu Zhao
Journal:  Front Biol (Beijing)       Date:  2010-08

Review 2.  Fragile X syndrome.

Authors:  J P Phillips; G A Wilson
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

Review 3.  Fragile X syndrome. Molecular and clinical insights and treatment issues.

Authors:  R J Hagerman
Journal:  West J Med       Date:  1997-02

Review 4.  Fragile X-associated disorders: a clinical overview.

Authors:  Anne Gallagher; Brian Hallahan
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

5.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles.

Authors:  Y Feng; L Lakkis; D Devys; S T Warren
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

6.  Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.

Authors:  Jocelyn N Galloway; David L Nelson
Journal:  Future Neurol       Date:  2009-11-01

7.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers.

Authors:  Jessica Ezzell Hunter; Emily Graves Allen; Ann Abramowitz; Michele Rusin; Mary Leslie; Gloria Novak; Debra Hamilton; Lisa Shubeck; Krista Charen; Stephanie L Sherman
Journal:  Behav Genet       Date:  2008-06-06       Impact factor: 2.805

Review 9.  Unstable mutations in the FMR1 gene and the phenotypes.

Authors:  Danuta Loesch; Randi Hagerman
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 10.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.